Use of Lactate-to-Albumin, CRP-to-Albumin, and Procalcitonin-to-Albumin Ratios to Predict Mortality in ICU Patients
NCT07242027
Cardiac Arrest, Cardiovascular Diseases
Zabrze, Silesian Voivodeship, Poland
View Trial DetailsNCT Number: NCT07061457
The goal of this observational study is to observe brachial-to-radial pressure gradient in critically-ill patients receiving vasoactive agents. The main questions it aims to answer are:
1. What is the frequency of brachial-to-radial gradient in critically-ill patients receiving vasoactive agents? 2. Is brachial-to-radial gradient greater in patients receiving high doses of vasoactive agents? 3. Is brachial-to-radial gradient associated with worse peripheral perfusion?
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
5 Szpital Wojskowy z Polikliniką w Krakowie, Krakow, Poland
Pathological conditions, such as arterial stenosis, use of vasoconstrictive drugs, or massive vasodilatation, can cause significant differences in mean arterial pressure (MAP) in different parts of the arterial system. For example, in the case of stenosis between the brachial and radial arteries, the pressure behind the stenosis is lower than in front of it, which can lead to erroneous conclusions about the actual arterial pressure. The use of vasoconstrictive drugs in patients with circulatory insufficiency can result in reduced peripheral arterial pressure transmission, as evidenced by studies showing lower pressures in the radial artery compared to the femoral artery. Inadequate MAP assessments can lead to excessive use of vasoactive drugs and fluids, increasing the risk of complications such as cardiac ischemia, atrial fibrillation, and renal failure. One method to detect a significant gradient between central MAP (e.g., aorta or femoral artery) and peripheral MAP is non-invasive, oscillometric measurement of MAP on the brachial artery and comparing it to MAP obtained from invasive radial access (known as NIBR-APG). The brachial-radial MAP gradient is highly correlated with the femoral-radial gradient and may be indicative of significantly higher central pressure. The aim of this project is to evaluate the frequency of the brachial-radial gradient phenomenon in patients undergoing vasoconstrictive treatment in intensive care units.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At baseline (after initial resuscitation). The gradient will be assessed only once, in a cross-sectional manner.
Frequency of significant brachial-to-radial gradient > 11 mmHg MAP
Time frame: At baseline (after initial resuscitation). The variables will be collected only once in a cross-sectional manner.
Odds ratio (OR) of norepinephrine equivalent dose and OR of other potential risk factors (diabetes, age and body surface area) for significant brachial-radial gradient (>11 mmHg MAP)
Time frame: At baseline (after initial resuscitation). Variables will be collected only once in a cross-sectional manner.
Correlation between brachial-to-radial gradient and capillary refill time
Time frame: At baseline (after initial resuscitation). Variables will be collected only once in a cross-sectional manner.
Correlation between brachial-to-radial gradient and lactate concentration
Jagiellonian University
Other
Brachial-radial Pressure Gradient Phenomenon in Critically Ill Patients Treated With Vasoactive Agents: an Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07242027
Cardiac Arrest, Cardiovascular Diseases
Zabrze, Silesian Voivodeship, Poland
View Trial DetailsNCT03917446
Circulatory Failure, Critical Illness
Gdansk, Poland
View Trial DetailsNCT03873675
Acute Kidney Injury, Circulatory Failure
Wroclaw, Lower Silesian Voivodeship, Poland
View Trial DetailsNCT01590511
Circulatory Failure, Pathologic Processes
Nîmes, France
View Trial Details